Cboe UK EUR

Aedifica NV/SA (AEDB.XC)

Compare
56.33
0.00
(0.00%)
At close: January 3 at 10:17:58 AM GMT
Loading Chart for AEDB.XC
  • Previous Close 56.33
  • Open 56.33
  • Bid 63.20 x --
  • Ask 58.20 x --
  • Day's Range 56.33 - 56.33
  • 52 Week Range 53.08 - 64.15
  • Volume 19
  • Avg. Volume 0
  • Market Cap (intraday) 2.753B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) 13.07
  • EPS (TTM) 4.31
  • Earnings Date Apr 29, 2025
  • Forward Dividend & Yield 3.90 (6.92%)
  • Ex-Dividend Date May 15, 2025
  • 1y Target Est --

Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 620 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden, Ireland and Spain, worth more than €5.8 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL 20, Euronext Brussels' leading share index. Moreover, since 2023, Aedifica has been part of the BEL ESG, the index tracking companies that perform best on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600 and GPR indices. Aedifica's market capitalisation was approx. €2.6 billion as at 20 February 2024.

www.aedifica.eu

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AEDB.XC

View More

Performance Overview: AEDB.XC

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is BEL 20 .

YTD Return

AEDB.XC
1.31%
BEL 20
3.19%

1-Year Return

AEDB.XC
9.67%
BEL 20
16.79%

3-Year Return

AEDB.XC
34.76%
BEL 20
12.26%

5-Year Return

AEDB.XC
37.54%
BEL 20
0.00%

Compare To: AEDB.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AEDB.XC

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    2.82B

  • Enterprise Value

    5.31B

  • Trailing P/E

    13.07

  • Forward P/E

    11.27

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.70

  • Price/Book (mrq)

    0.74

  • Enterprise Value/Revenue

    15.28

  • Enterprise Value/EBITDA

    21.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    59.11%

  • Return on Assets (ttm)

    2.87%

  • Return on Equity (ttm)

    5.67%

  • Revenue (ttm)

    346.54M

  • Net Income Avi to Common (ttm)

    204.83M

  • Diluted EPS (ttm)

    4.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.45M

  • Total Debt/Equity (mrq)

    71.59%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AEDB.XC

View More

Company Insights: AEDB.XC

Research Reports: AEDB.XC

View More